World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
27623
World Ranking
14563
National Ranking
560

Sandro Barni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sandro Barni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 736 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sandro Barni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sandro Barni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sandro Barni is affiliated with the Mario Negri Institute for Pharmacological Research in Italy and has made significant contributions in the field of Medicine, with a particular focus on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Cancer Research, and Internal Medicine.

The scientist's research encompasses several main topics, including:

  • Breast Cancer Treatment Studies
  • Venous Thromboembolism Diagnosis and Management
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cancer survivorship and care
  • Cancer Treatment and Pharmacology
  • Advanced Breast Cancer Therapies
  • Economic and Financial Impacts of Cancer

Among recent papers coauthored by Barni are the following:

  • Association of Obesity With Survival Outcomes in Patients With Cancer, 2021, JAMA Network Open
  • Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study, 2020, Advances in Therapy
  • Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study, 2020, Journal of Clinical Medicine
  • Effects of hypertension on cancer survival: A meta-analysis, 2021, European Journal of Clinical Investigation
  • Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort, 2023, Journal of Thrombosis and Haemostasis

Frequent coauthors of the scientist include:

  • Fausto Petrelli
  • Antonio Ghidini
  • Alberto Zaniboni
  • Giuseppe Aprile
  • Luigi Cavanna

Publications by the scientist often appear in the following venues:

  • PubMed
  • Journal of Thrombosis and Haemostasis
  • Clinical Breast Cancer
  • JAMA Network Open
  • Advances in Therapy

Best Publications

  • Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

    Giancarlo Agnelli;Gualberto Gussoni;Carlo Bianchini;Melina Verso

  • Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis

    Fausto Petrelli;Gianluca Tomasello;Karen Borgonovo;Michele Ghidini

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis

    Filippo Pietrantonio;Fausto Petrelli;Andrea Coinu;Maria Di Bartolomeo

  • A New Palliative Prognostic Score: A First Step for the Staging of Terminally Ill Cancer Patients

    Marco Pirovano;Marco Maltoni;Oriana Nanni;Mauro Marinari

  • Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)

    E. Mari;I. Floriani;A. Tinazzi;A. Buda

  • Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

    L. Crinò;Giorgio V. Scagliotti;S. Ricci;F. De Marinis

  • Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

    Paolo Maione;Francesco Perrone;Ciro Gallo;Luigi Manzione

  • A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

    Melina Verso;Giancarlo Agnelli;Sandro Barni;Giampietro Gasparini

  • Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status.

    P Lissoni;S Barni;M Mandalà;A Ardizzoia

  • Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.

    Fausto Petrelli;Giovanni Sgroi;Enrico Sarti;Sandro Barni

  • Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis

    Fausto Petrelli;Andrea Coinu;Mary Cabiddu;Mara Ghilardi

  • Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies.

    Fausto Petrelli;Mary Cabiddu;Andrea Coinu;Karen Borgonovo

  • Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.

    Fausto Petrelli;Alessio Cortellini;Alice Indini;Gianluca Tomasello

  • Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients

    Fausto Petrelli;G. Viale;M. Cabiddu;S. Barni

  • Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

    G Gasparini;O Caffo;S Barni;L Frontini

  • A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

    Domenica Lorusso;Fausto Petrelli;Andrea Coinu;Francesco Raspagliesi

  • FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies.

    Fausto Petrelli;Andrea Coinu;Karen Borgonovo;Mary Cabiddu

  • Increased Survival Time in Brain Glioblastomas by a Radioneuroendocrine Strategy with Radiotherapy plus Melatonin Compared to Radiotherapy Alone

    Paolo Lissoni;Sofia Meregalli;Luca Nosetto;Sandro Barni

  • The combined contribution of social support and coping strategies in predicting post-traumatic growth: a longitudinal study on cancer patients.

    Marta Scrignaro;Sandro Barni;Maria Elena Magrin

Frequent Co-Authors

Roberto Labianca
Roberto Labianca Mario Negri Institute for Pharmacological Research
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
Mario Mandalà
Mario Mandalà European Institute of Oncology
Daniele Santini
Daniele Santini Università Campus Bio-Medico
Valter Torri
Valter Torri Mario Negri Institute for Pharmacological Research
Giuseppe Tonini
Giuseppe Tonini Università Campus Bio-Medico
Francesco Cognetti
Francesco Cognetti Sapienza University of Rome
Antonio Russo
Antonio Russo University of Palermo
Filippo de Braud
Filippo de Braud University of Milan
Alfredo Berruti
Alfredo Berruti University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require the traditional route of medical school. Many students today are choosing flexible online education for various healthcare professions. Options range from entry-level certifications to advanced degrees, allowing for a range of career opportunities in healthcare—from administration to direct patient care.

For those interested in healthcare administration, medical billing and coding online courses cost less and can open doors to in-demand roles in medical offices. Nursing also offers several online study options. You can explore cheapest online nurse practitioner programs or pursue affordable nursing programs online for licensed practical or registered nursing credentials.

For those wanting to advance into academic or leadership roles, earning a doctorate in nursing education online programs may be the right path. These diverse online options make it possible for students at all stages of their careers to enter or grow in the medical field without relocating or disrupting their lives.

Best Scientists Citing Sandro Barni

Trending Scientists

Recently Published Articles